Does Oramed Pharmaceuticals (ORMP) pay a dividend?
Yes. Oramed Pharmaceuticals (ORMP) pays a dividend: $0.25 per share over the last twelve months, a dividend yield of 6.33% at the latest close.
The payout takes about 6.2% of earnings.
Based on TTM and annual data · Not a buy/sell signal
Score Breakdown
Safety
40% of composite
Growth
35% of composite
Income
25% of composite
Composite = Safety (50) × 0.40 + Growth (0) × 0.35 + Income (100) × 0.25 = 45
Dividend Safety
Earnings Payout
6.2%
FCF Payout
–
FCF Coverage
-0.5x
Dividend Growth
Per Share (TTM)
$0.25
Growth Streak
–
CAGR
–
Dividend history
| Fiscal year | Per share | Change |
|---|---|---|
| 2025 | $0.25 |
All 1 fiscal years we hold. Each payment counts toward the fiscal year it is paid for, so a final dividend paid in spring belongs to the year before. Figures are adjusted for stock splits, so a fall is a cut.
Computed from SEC filings. Ex-dividend and payment dates are not part of those filings, so they are not shown here. This is analysis, not investment advice.
Dividend Income
Annual DPS (TTM)
$0.25
Annual Income / $10K
$633
Payment frequency, ex-dividend and payment dates are not available from SEC filings. Check your broker or the company's investor relations page for the schedule.
Oramed Pharmaceuticals (ORMP) dividend: yield, safety and growth
Frequently asked
Does Oramed Pharmaceuticals (ORMP) pay a dividend, and how much?+
Yes, Oramed Pharmaceuticals pays a regular dividend of about $0.25 per share per year (a yield of roughly 6.3%). That is a payout ratio of about 6.2% of earnings, so it is not currently covered by free cash flow. A low headline yield is not the same as a weak dividend: what matters is how well earnings and cash flow cover the payout, not the percentage alone. The full payout history and per-share figures are on this dividends tab.
Is Oramed Pharmaceuticals's dividend safe?+
Oramed Pharmaceuticals's dividend looks not currently covered by free cash flow, with free cash flow covering the payout about -0.5 times over. Intrinsiqq scores its dividend safety at 50 out of 100, weighing the payout ratio, free-cash-flow coverage and balance-sheet strength. Safety matters more than yield: a payout you can rely on beats a high one you cannot.
What is Oramed Pharmaceuticals's dividend payout ratio?+
Oramed Pharmaceuticals pays out about 6.2% of its earnings as dividends. A lower payout ratio leaves more room to keep raising the dividend and to absorb a bad year, while a very high ratio can signal a payout under pressure. On this measure the dividend is not currently covered by free cash flow. See the dividend-safety breakdown for the free-cash-flow view, which is often more telling than earnings.
SourceDividend analysis computed from the 10-Q filed 10 Aug 2026, covering the period ending 30 Jun 2026, as reported to the SEC. Data last refreshed 12 Oct 2026. How this is calculated.
Fiscal year ends Dec. Earnings payout = dividends / net income. FCF payout = dividends / FCF. Yield = TTM DPS / price.
Peers
Pharmaceutical Preparations · Pick stocks to compare with ORMP
Held by ETFs
ORMP is in 1 US ETF. The largest of them, with ORMP's weight in each:
Spot a number that looks wrong? Check it in ORMP's SEC filings or
Download this analysis as a PDF (Pro)
Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Keep analysing ORMP
Create a free account and get 14 days of Premium: every stock and every tool.
- Unlimited stocks
- Stock screener
- Portfolio tracker
- Editable DCF
- Compare side by side
- Unlimited alerts
No card. Moves to Free after, unless you upgrade.
Already have an account?
Or come back tomorrow. Stocks on your watchlist are always free to view.